Daniel Benjamin  Jr., MD, PhD, MPH Daniel Benjamin  Jr., MD, PhD, MPH

Daniel Benjamin Jr., MD, PhD, MPH

Pediatric Infectious Diseases Specialist

No ratings available.
question Circle Img
Duke Health Provider What's this?
Insurance

Duke Health contracts with most major health insurance carriers and transplant networks, including the ones listed below. Before scheduling your appointment, we strongly recommend you contact your insurance company to verify that the Duke Health location or provider you plan to visit is included in your network. Your insurance company will also be able to inform you of any co-payments, co–insurances, or deductibles that will be your responsibility. If you proceed in scheduling an appointment and your health insurance benefits do not participate with Duke, your out of pocket liability may be higher. We will contact you regarding your coverage and patient liability. If you are uninsured, learn more about our financial assistance policy

Click to see a list of accepted insurance plansHide accepted insurance plans
Contact
919-668-7081 Office number
919-681-9457
Fax number
Insurance

Duke Health contracts with most major health insurance carriers and transplant networks, including the ones listed below. Before scheduling your appointment, we strongly recommend you contact your insurance company to verify that the Duke Health location or provider you plan to visit is included in your network. Your insurance company will also be able to inform you of any co-payments, co–insurances, or deductibles that will be your responsibility. If you proceed in scheduling an appointment and your health insurance benefits do not participate with Duke, your out of pocket liability may be higher. We will contact you regarding your coverage and patient liability. If you are uninsured, learn more about our financial assistance policy

Click to see a list of accepted insurance plansHide accepted insurance plans

Contact
WHERE I PROVIDE CARE
Profile
ABOUT ME

I’m a pediatric infectious diseases specialist. The patients that I see are primarily very immune compromised children, so premature infants with severe infection, children with HIV, and children who had a stem cell transplant or chemotherapy and are at high risk for infection. My clinical care focuses on providing ideal therapy and ideal dosing to help prevent severe neurologic injury after infections in premature infants. With premature infants, they can’t tell you their symptoms and there’s no one perfect answer with dosage, so the medicine is really as much art as it is facts. And that’s really my favorite part of my job – figuring out the right dose for that patient and using that knowledge to help the next patient who comes into the unit. Outside of work, I participate in Olympic weightlifting, CrossFit, and baseball with my wife and four children.

LANGUAGES I SPEAK
English
LEARN MORE ABOUT ME
Training
EDUCATION
MD, University of Virginia School of Medicine, 1995
MPH, University of North Carolina, 2001
PhD, Epidemiology, University of North Carolina–Chapel Hill, 2003
RESIDENCY
Pediatrics, University of Virginia Medical Center, 1998
FELLOWSHIP
Infectious Disease, Duke University Medical Center, 2001
BOARD CERTIFICATION
American Board of Pediatrics, General Pediatrics
American Board of Pediatrics, Pediatric Infectious Disease
Clinical Focus and Research
MY RESEARCH INTERESTS

I am the Principal Investigator and Chair of the National Institute of Child Health and Human Development’s Pediatric Trials Network, which is responsible for designing and leading clinical trials of off-patent medicines in children of all ages across all therapeutic areas. We have established or are actively studying the correct dosing and safety of more than 50 of the most commonly used medicines in children.

PUBLICATIONS
View Daniel Benjamin 's publications on PubMed
Industry Relationships and Collaborations
This faculty member (or a member of their immediate family) has a working relationship (i.e. consulting, research, and/or educational services) with the companies listed below. These relations have been reported to the health system leadership and, when appropriate, management plans are in place to address potential conflicts.
  • Allergen
  • Astellas Pharma Inc.
  • AstraZeneca
  • Cempra Pharmaceuticals
  • Commense
  • Pfizer Inc.
  • The Medicines Company
  • UCB Pharma